إعلان
إعلان
SANA
Sana Biotechnology, Inc. Common Stock
4.57
USDبرعاية
+0.05
+1.08%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
4.58
+0.02
+0.35%
تقارير أرباح SANA
النسبة الإيجابية المفاجئة
SANA تفوق 15 من 20 آخر التقديرات.
75%
التقرير التالي
بيانات التقرير القادم
١٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.13
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-18.75%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-38.10%
Sana Biotechnology, Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, SANA reported earnings of -0.16 USD per share (EPS) for Q3 25, beating the estimate of -0.18 USD, resulting in a 12.81% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.99% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 المحللين forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an نقصان of -18.75% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Sana Biotechnology, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Sana Biotechnology, Inc. Common Stock reported EPS of -$0.16, beating estimates by 12.81%, and revenue of $0.00, 0% as expectations.
How did the market react to Sana Biotechnology, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.99%, changed from $4.05 before the earnings release to $4.09 the day after.
When is Sana Biotechnology, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٦ مارس ٢٠٢٦.
What are the forecasts for Sana Biotechnology, Inc. Common Stock's next earnings report?
Based on 12
المحللين, Sana Biotechnology, Inc. Common Stock is expected to report EPS of -$0.13 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان